NURS FPX 4055 Assignment 4 Health Promotion Plan Presentation

Name

Capella university

NURS-FPX4055 Optimizing Population Health through Community Practice

Prof. Name

Date

Health Promotion Plan Presentation

Good morning, and thank you all for joining today’s session. This presentation is designed to inform and empower adolescents and young adults aged 11 to 26 in Schwenksville, Pennsylvania, regarding the prevention of Human Papillomavirus (HPV). Our focus is on understanding HPV’s connection to various cancers, the advantages of timely vaccination, and effective strategies to communicate with healthcare providers and family about the vaccine. This initiative is built on previously established SMART goals and aligns with the national objectives outlined in Healthy People 2030.

Presentation Roadmap

The session will guide participants through a comprehensive overview of HPV and its health implications. It will include key facts about the virus, its transmission, and associated cancer risks. The safety and efficacy of the HPV vaccine will be emphasized, encouraging timely vaccination. To facilitate informed discussions, communication strategies with healthcare professionals and family members will be explored. Engagement is ensured through interactive discussions and a post-session quiz to assess knowledge and confidence levels.

Key Information and Communication Strategies

HPV Overview and Cancer Link

HPV is a prevalent virus transmitted primarily through sexual contact. While often asymptomatic, persistent infections—especially with high-risk strains such as HPV 16 and 18—can lead to serious health conditions, including cervical, anal, throat, and genital cancers (Huber et al., 2021). In rural Pennsylvania communities like Schwenksville, HPV vaccination rates remain low, with only 48.7% of adolescents fully vaccinated, contributing to higher HPV-related cancer incidence (PA.gov, 2025). Raising awareness and improving immunization rates in such regions is vital to reducing this public health burden.

Benefits of Timely Vaccination

HPV vaccination offers significant protection against several types of cancers and genital warts. The vaccine is most effective when administered around ages 11 or 12—prior to potential exposure to the virus. The early immune response is both strong and long-lasting (Hoes et al., 2021). Vaccinating at a young age not only protects individuals but also helps establish community-wide immunity, especially when high coverage is achieved (Xu et al., 2024).

The following table outlines key benefits of early HPV vaccination:

Benefit	Explanation
Stronger Immune Response	Early vaccination triggers a more robust and long-term immune defense.
Cervical Cancer Prevention	Reduces the risk of one of the most common cancers in women globally.
Protection for Both Sexes	Decreases chances of anal, penile, and throat cancers in all genders (Cheng et al., 2020).
Genital Warts Reduction	Prevents certain HPV strains responsible for genital warts and associated stigma.
Community-Level Immunity	Slows virus spread and protects vulnerable, unvaccinated individuals.

Strategies for Effective Communication

Constructive dialogue about HPV vaccination with providers and family is critical. Evidence-based facts from sources such as the CDC and WHO can effectively dispel misconceptions. Asking informed questions during conversations encourages open dialogue and personalizes decision-making (Kassymbekova et al., 2023). Addressing myths—such as the notion that vaccination promotes early sexual behavior—requires factual clarification about the vaccine’s cancer prevention purpose.

Recommended Communication Approaches

Strategy	Application
Share Trusted Information	Use data from CDC/WHO to demonstrate safety and effectiveness of the vaccine.
Ask Thoughtful Questions	Promote open conversations with queries about long-term benefits and side effects.
Debunk Myths	Counter misinformation calmly and factually.

SMART Goals and Evaluation

Developed SMART Goals

Our session goals were designed to be measurable and actionable. The SMART goals included:

1. Knowledge: Ensure 90% of participants identify at least three key facts about HPV and cancer by session end.
2. Commitment to Vaccination: Have 80% of attendees pledge to schedule the first dose of the vaccine within 30 days.
3. Communication Confidence: Enable 85% to feel confident in discussing the vaccine with others.

These goals aim to increase awareness, inspire preventative action, and strengthen health communication at both individual and community levels.

SMART Goals Evaluation

Session outcomes were largely positive. A summary of the goal outcomes is presented below:

SMART Goal	Target	Outcome	Status
Identify 3 HPV facts	90%	92.5%	Achieved
Commit to vaccination within 30 days	80%	75%	Partially Achieved
Confidence in discussing HPV vaccination	85%	85%	Achieved

Participants showed strong engagement, particularly in discussions. However, challenges emerged. Some adolescents were hesitant to commit immediately to vaccination, preferring to consult family. Others expressed uncertainty in addressing myths confidently.

To improve future sessions, the following changes are recommended:

• Provide time for real-time family discussion during the session.
• Incorporate structured role-play for myth-busting.
• Extend or schedule follow-ups for hesitant participants.

Evaluation in Relation to Healthy People 2030 Objectives

The session aligned well with Healthy People 2030 objectives, particularly in enhancing awareness about HPV and boosting confidence in vaccination. The session contributed meaningfully to increasing knowledge and communication readiness, as reflected in 92.5% knowledge gain and 85% communication confidence.

However, the 75% vaccination commitment highlights a gap in achieving the national target of early vaccination initiation. Persistent misconceptions about safety suggest a continued need for myth-focused education and deeper family engagement strategies. Future educational programming should integrate extended resources, real-life testimonials, and evidence-based updates to reinforce national health promotion priorities (U.S. Department of Health and Human Services, n.d.; Xu et al., 2024).

Conclusion

In summary, this session underscored the critical role of HPV vaccination in cancer prevention among youth in Schwenksville, PA. Guided by clearly defined SMART goals, participants gained important knowledge and improved confidence, though gaps in vaccine commitment suggest areas for refinement. By continuing to strengthen community education and align efforts with Healthy People 2030, we can work towards a healthier, well-informed future for adolescents and young adults.

References

Cheng, L., Wang, Y., & Du, J. (2020). Human papillomavirus vaccines: An updated review. Vaccines, 8(3), 391. https://doi.org/10.3390/vaccines8030391

Hoes, J., Pasmans, H., Schurink-van ’t Klooster, T. M., van der Klis, F. R. M., Donken, R., Berkhof, J., & de Melker, H. E. (2021). Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge. Human Vaccines & Immunotherapeutics, 18(1). https://doi.org/10.1080/21645515.2021.1908059

NURS FPX 4055 Assignment 4 Health Promotion Plan Presentation

Huber, J., Mueller, A., Sailer, M., & Regidor, P.-A. (2021). Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women’s Health, 17, 174550652110207. https://doi.org/10.1177/17455065211020702

Kassymbekova, F., Zhetpisbayeva, I., Tcoy, E., Dyussenov, R., Davletov, K., Rommel, A., & Glushkova, N. (2023). Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: A mixed-methods study protocol. BMJ Open, 13(9), e074097. https://doi.org/10.1136/bmjopen-2023-074097

PA.gov. (2025). Dear VFC provider. https://www.pa.gov/content/dam/copapwp-pagov/en/health/documents/topics/documents/programs/immunizations/3.3.25%20-%202025%20HPV%20Call-to-Action%20Letter%20and%20Resources.pdf

U.S. Department of Health and Human Services. (n.d.). Vaccination – Healthy People 2030. Health.gov. https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination

Xu, M., Choi, J., Capasso, A., & DiClemente, R. (2024). Improving HPV vaccination uptake among adolescents in low-resource settings: Sociocultural and socioeconomic barriers and facilitators. Adolescent Health Medicine and Therapeutics, 15, 73–82. https://doi.org/10.2147/ahmt.s394119

NURS FPX 4055 Assignment 4 Health Promotion Plan Presentation